BioLargo, Inc. Files 8-K Report

Ticker: BLGO · Form: 8-K · Filed: Oct 20, 2025 · CIK: 880242

Sentiment: neutral

Topics: sec-filing, 8-k, disclosure

TL;DR

BioLargo filed an 8-K on 10/20/25 - check for updates.

AI Summary

On October 20, 2025, BioLargo, Inc. filed an 8-K report. The filing indicates a Regulation FD Disclosure and includes Financial Statements and Exhibits. No specific financial figures or material events were detailed in the provided text excerpt.

Why It Matters

This 8-K filing signals that BioLargo, Inc. is providing updated information or disclosures to the SEC, which could be material to investors.

Risk Assessment

Risk Level: low — The provided text is a standard SEC filing notification and does not contain specific material events or financial data that would indicate a high risk.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

The filing serves as a Current Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, indicating a Regulation FD Disclosure and including Financial Statements and Exhibits.

What is the exact date of the earliest event reported?

The date of the earliest event reported is October 20, 2025.

Where are BioLargo, Inc.'s principal executive offices located?

The principal executive offices are located at 14921 Chestnut St., Westminster, California 92683.

What is BioLargo, Inc.'s IRS Employer Identification Number?

BioLargo, Inc.'s IRS Employer Identification No. is 65-0159115.

Has BioLargo, Inc. had previous names?

Yes, the company was formerly known as NUWAY MEDICAL INC and NUWAY ENERGY INC, with name changes occurring on February 5, 2003, and August 15, 2001, respectively. It was also formerly LATIN AMERICAN CASINOS INC with a name change on May 20, 1996.

Filing Stats: 594 words · 2 min read · ~2 pages · Grade level 10 · Accepted 2025-10-20 17:12:34

Filing Documents

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. BioLargo, Inc., intends to present the slides attached as Exhibit 99.1, which are incorporated herein by reference, at the LD Micro Main Event XIX at the Hotel del Coronado in San Diego, California, on Monday, October 20, at 2:00 p.m. Pacific Time. The information in this Item 7.01 of this Current Report on Form 8-K and Exhibit 99.1 attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained in this Item 7.01 and in the slides attached as Exhibit 99.1 to this Current Report shall not be incorporated by reference into any filing with the SEC made by the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing. The Company undertakes no duty or obligation to update or revise the information contained in this report, although it may do so from time to time as its management believes is appropriate. Any such updating may be made through the filing of other reports or documents with the SEC, through press releases or through other public disclosures. For important information about forward looking statements, see the information under the heading "Safe Harbor Act" in Exhibit 99.1 attached hereto.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Presentation slides 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: October 20, 2025 BIOLARGO, INC. By: /s/ Dennis P. Calvert Dennis P. Calvert President and Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing